PARP1 and breast carcinoma: Moreover, a recent meta-analysis carried out in a large retrospective gene expression dataset revealed that both PARP-1 mRNA and PARP-1 evaluated by immunohistochemistry were overexpressed in the subset of breast cancer with the worst prognosis, in terms of metastasis-free survival and overall survival.